FindMyKOL
Clinical trialNCT04815564Active, not recruitingInterventional

Clear Aligners for the Treatment of Dental Malocclusion in OI

NCT04815564 is an interventional trial sponsored by Baylor College of Medicine. As of 21 Nov 2026, it is active and no longer recruiting. It studies Osteogenesis Imperfecta. The registry lists an enrollment of 57 participants at 3 sites in 2 countries. The registry lists a start date of 1 Aug 2022 and a primary completion date of 1 Aug 2027.

SponsorBaylor College of Medicine →Enrollment57Osteogenesis Imperfecta
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04815564
FieldValue
Registry IDNCT04815564
StatusActive not recruiting
Study typeInterventional trial
Lead sponsorBaylor College of Medicine
Enrollment57
Registered sites3
Countries2
ConditionsOsteogenesis Imperfecta
Start1 Aug 2022
Primary completion1 Aug 2027
Study completion1 Dec 2027
Last update posted18 Aug 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Misalignment of teeth and jaws (also called malocclusion) is a common life altering problem facing many individuals with Osteogenesis Imperfecta (OI). The presence of Dentinogenesis Imperfecta in teeth of OI individuals makes the use of conventional orthodontics in the form of braces very challenging. Clear aligners are newer form of orthodontic treatment and is less invasive than braces. Therefore, the aim of our study is to evaluate the efficiency and safety of using Invisalign clear aligners for orthodontic treatment in individuals with Osteogenesis Imperfecta. We seek individual with Osteogenesis Imperfecta, with mild to moderate malocclusion and no prior history of orthodontic treatment. This study will be held at three sites - McGill University, University of California Los Angeles and National Institute of Dental and Craniofacial research. This study will for the first time, help define guidelines for safe and efficient orthodontic treatment using clear aligners in individuals with Osteogenesis Imperfecta. If successful, this approach can rapidly be implemented into clinical practice, as the Invisalign system is readily available to orthodontists.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • University of California Los Angeles

    Los Angeles

Maryland, United States1 site
  • Nidcr/nih

    Bethesda

Canada1 site
  • Mcgill University

    Montreal, Quebec

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 1 siteMD1DelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Outside the United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04815564

Each answer restates registry values shown on this page.

What is NCT04815564?

NCT04815564 is an interventional trial sponsored by Baylor College of Medicine. It studies Osteogenesis Imperfecta.

Is NCT04815564 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT04815564?

The registry names Deborah Krakow (principal investigator, University of California, Los Angeles), Janice Lee (principal investigator, NIDCR/NIH), Jean-Marc Retrouvey (principal investigator, Baylor College of Medicine) and 1 more official as overall officials.

Where does NCT04815564 run?

The registry lists 3 sites in 2 countries. Most sites are in these countries: United States (2) and Canada (1).

When is NCT04815564 expected to complete?

The registry lists a primary completion date of 1 Aug 2027 and a study completion date of 1 Dec 2027. The sponsor last updated the record on 18 Aug 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.